News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

Banner Pharmacaps Inc. Receives FDA Approval for Nimodipine Softgel Capsules


1/23/2008 11:06:33 AM

HIGH POINT, N.C.--(BUSINESS WIRE)--Banner Pharmacaps Inc., a leader in the pharmaceutical industry for the development of soft gelatin dosage form technology, today announced that the US Food & Drug Administration has granted approval for the Company’s Abbreviated New Drug Application (ANDA) for Nimodipine 30 mg soft gelatin capsules.

Read at BioSpace.com

comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES